Bargains begin luring big banks back to China bets for 2023



*

Consensus building about China's recovery prospects

*

Less agreement about investment decisions; but bulls regrouping

*

Citi, Goldman, BofA analysts are positive

By Summer Zhen and Tom Westbrook

HONG KONG, Dec 5 (Reuters) - As Chinese assets whipsaw around hopes and fears over the country's path out of the pandemic, big offshore investors are slowly leaving the sidelines as they plot a cautious return to one of the year's worst-performing equity markets.

The drumbeat of bullish outlooks has grown a bit louder over recent weeks as analysts at Citi, Bank of America, and J.P. Morgan upgraded recommendations, and said re-opening can lift consumer-exposed stocks that have fallen to attractive prices.

Goldman Sachs forecasts 16% index returns for MSCI China .dMICN00000PUS and CSI300 .CSI300 next year and recommends an overweight allocation to China, while J.P.Morgan expects a 10% potential upside in MSCI China in 2023.

Morgan Stanley upgraded its recommendation to overweight on Monday with an increase in exposure to consumer stocks as reopening prospects improve. Bank of America Securities turned bullish in November, with its China equity strategist, Winnie Wu picking internet and financial stocks to lead the short-term rebound.

Overall, however, while consensus is building around economic recovery, there is hesitation over timing and weight of capital to allocate to China as the regulatory and political risks that have stalked its equity markets for the past couple of years remain.

"We would rather miss the first 10% gains, and wait until when we can see clearer, ongoing signs of policy pivot," said Eva Lee, head of Greater China equities at UBS Global Wealth Management, the world's biggest wealth manager by assets.

"We have experienced several rounds of policy back and forth in 2022," she added, referring to both COVID and property policies. UBS Global Wealth Management recommends a market-neutral allocation to Chinese stocks.

There is some evidence that the first leg of an early recovery happened last week, with the Hang Seng .HSI up 6% and closing out its best month since 1998 with a 27% rise through November. The yuan posted its best week since 2005 on Friday.

Market participants say the asset moves so far - coming with COVID cases at record highs and only hints of a shift in authorities' response - suggest light positioning in China that could lift markets if it were to solidify into steady inflows.

U.S. institutional investors continue to reduce U.S.-listed Chinese American Depositary Receipts (ADRs) so far in the fourth quarter with estimated outflows of $2.9 billion.

Short interest in ADRs was also up by 11% last month, Morgan Stanley data as of Nov. 29 shows. Societe Generale analysts downgraded their recommended China allocation from overweight to neutral.

ACCUMULATE ON WEAKNESS

China's market weathered a perfect storm this year, with U.S.-China tension threatening the U.S. listings of Chinese companies, a credit crisis crunching the once-mighty real estate sector and COVID restrictions curtailing growth.

The CSI300 has lost 22% and the Hang Seng 20% so far this year, compared with a 16% loss for world stocks .MIWD00000PUS .

The policy response has been monetary easing, steadily increasing support for the property sector and the easing of some of the strict COVID rules. It is yet to win investors' full approval, since unpredictable regulation and politics still hang over profitability, and domestic confidence remains fragile.

"Monetary easing has become ineffective, just like pushing a string," said Chi Lo, senior strategist at BNP Paribas Asset Management. He is sticking with a preference for sectors that are likely to receive policy tailwinds.

"We continue to focus on the three key themes which are in line with China’s long-term growth target: technology and innovation, consumption upgrading and industry consolidation," he said.

Goldman Sachs also recommends policy-aligned bets on sectors such as technology hardware and profitable state-owned businesses.

Politics aside, price and the prospect that rate hikes put a lid on U.S. equities next year has also got money managers starting to weigh up the risk of missing out.

A 27% drop for the MSCI China index this year has left its price-to-earnings ratio at 9.55 against a 10-year average of 11.29.

"It's now getting risky to be really underweight or short China as many of the hedge funds were," said Sean Taylor, Asia-Pacific chief investment officer at asset manager DWS, which thinks there is scope for a 15-20% rally in China next year.

"Our view is to accumulate, on weakness, reopening beneficiaries, and particularly those driven by the consumer," said Taylor.


Reporting by Summer Zhen Editing by Shri Navaratnam

면책조항: XM Group 회사는 체결 전용 서비스와 온라인 거래 플랫폼에 대한 접근을 제공하여, 개인이 웹사이트에서 또는 웹사이트를 통해 이용 가능한 콘텐츠를 보거나 사용할 수 있도록 허용합니다. 이에 대해 변경하거나 확장할 의도는 없습니다. 이러한 접근 및 사용에는 다음 사항이 항상 적용됩니다: (i) 이용 약관, (ii) 위험 경고, (iii) 완전 면책조항. 따라서, 이러한 콘텐츠는 일반적인 정보에 불과합니다. 특히, 온라인 거래 플랫폼의 콘텐츠는 금융 시장에서의 거래에 대한 권유나 제안이 아닙니다. 금융 시장에서의 거래는 자본에 상당한 위험을 수반합니다.

온라인 거래 플랫폼에 공개된 모든 자료는 교육/정보 목적으로만 제공되며, 금융, 투자세 또는 거래 조언 및 권고, 거래 가격 기록, 금융 상품 또는 원치 않는 금융 프로모션의 거래 제안 또는 권유를 포함하지 않으며, 포함해서도 안됩니다.

이 웹사이트에 포함된 모든 의견, 뉴스, 리서치, 분석, 가격, 기타 정보 또는 제3자 사이트에 대한 링크와 같이 XM이 준비하는 콘텐츠 뿐만 아니라, 제3자 콘텐츠는 일반 시장 논평으로서 "현재" 기준으로 제공되며, 투자 조언으로 여겨지지 않습니다. 모든 콘텐츠가 투자 리서치로 해석되는 경우, 투자 리서치의 독립성을 촉진하기 위해 고안된 법적 요건에 따라 콘텐츠가 의도되지 않았으며, 준비되지 않았다는 점을 인지하고 동의해야 합니다. 따라서, 관련 법률 및 규정에 따른 마케팅 커뮤니케이션이라고 간주됩니다. 여기에서 접근할 수 있는 앞서 언급한 정보에 대한 비독립 투자 리서치 및 위험 경고 알림을 읽고, 이해하시기 바랍니다.

우리는 웹사이트에서 최고의 경험을 전해드리기 위해 쿠키를 사용하고 있습니다. 자세히 읽거나 쿠키 설정을 변경하세요.

리스크 경고: 고객님의 자본이 위험에 노출 될 수 있습니다. 레버리지 상품은 모든 분들에게 적합하지 않을수 있습니다. 당사의 리스크 공시를 참고하시기 바랍니다.